Scientists have discovered a family of chemical compounds that could help develop a new class of anti-malarial drugs capable of staving off the deadly disease. Malaria caused by Plasmodium parasites transmitted through the bites of infected mosquitoes affected about 225 million people in 2009 and killed nearly 800000 (WHO). Elizabeth Winzeler researcher at California's Scripps Research Institute demonstrated that the class of compounds was more effective against malaria than commercially available drugs. Most anti-malarial drugs are only effective during the blood stage and those that do work have notable side-effects in the liver the journal Science reported. However the new class
